Literature DB >> 22025704

Reciprocal seasonal variation in vitamin D status and tuberculosis notifications in Cape Town, South Africa.

Adrian R Martineau1, Shepherd Nhamoyebonde, Tolu Oni, Molebogeng X Rangaka, Suzaan Marais, Nonzwakazi Bangani, Relebohile Tsekela, Lizl Bashe, Virginia de Azevedo, Judy Caldwell, Timothy R Venton, Peter M Timms, Katalin A Wilkinson, Robert J Wilkinson.   

Abstract

Vitamin D deficiency is associated with susceptibility to tuberculosis (TB) in HIV-uninfected people in Europe, but it is not known whether such an association exists among HIV-infected people in subtropical Africa. We conducted a cross-sectional study to determine whether vitamin D deficiency was associated with susceptibility to active TB in HIV-uninfected (n = 196) and HIV-infected (n = 174) black Africans in Cape Town, South Africa. We also investigated whether there was evidence of seasonal variation in vitamin D status and TB notifications in this setting over an 8-y period. Vitamin D deficiency (serum 25-hydroxyvitamin D [25(OH)D] <50 nmol/L) was present in 232 (62.7%) of 370 participants and was associated with active TB in both HIV-uninfected (odds ratio = 5.2, 95% confidence interval: 2.8-9.7; P < 0.001) and HIV-infected (odds ratio = 5.6, 95% confidence interval: 2.7-11.6; P < 0.001) people. Vitamin D status varied according to season: The mean serum 25(OH)D concentration was highest in January through March and lowest in July through September (56.8 vs. 30.7 nmol/L, respectively; P < 0.001). Reciprocal seasonal variation in TB notifications was observed: The mean number of TB notifications per quarter for Cape Town in 2003 to 2010 was lowest in April through June and highest in October through December (4,222 vs. 5,080; P < 0.001). Vitamin D deficiency is highly prevalent among black Africans in Cape Town and is associated with susceptibility to active TB both in the presence and absence of HIV infection. Reciprocal seasonal variation in serum 25(OH)D concentration and TB notifications suggests that seasonal variations in vitamin D status and TB incidence in this setting are causally related.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22025704      PMCID: PMC3223428          DOI: 10.1073/pnas.1111825108

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  37 in total

1.  Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin.

Authors:  Philip T Liu; Steffen Stenger; Dominic H Tang; Robert L Modlin
Journal:  J Immunol       Date:  2007-08-15       Impact factor: 5.422

2.  Influence of vitamin D deficiency and vitamin D receptor polymorphisms on tuberculosis among Gujarati Asians in west London: a case-control study.

Authors:  R J Wilkinson; M Llewelyn; Z Toossi; P Patel; G Pasvol; A Lalvani; D Wright; M Latif; R N Davidson
Journal:  Lancet       Date:  2000-02-19       Impact factor: 79.321

3.  Poor nutritional status in older black South Africans.

Authors:  K E Charlton; L T Bourne; K Steyn; J A Laubscher
Journal:  Asia Pac J Clin Nutr       Date:  2001       Impact factor: 1.662

4.  The effect of season and latitude on in vitro vitamin D formation by sunlight in South Africa.

Authors:  J M Pettifor; G P Moodley; F S Hough; H Koch; T Chen; Z Lu; M F Holick
Journal:  S Afr Med J       Date:  1996-10

5.  Enhancement of human immunodeficiency virus 1 replication in monocytes by 1,25-dihydroxycholecalciferol.

Authors:  P R Skolnik; B Jahn; M Z Wang; T R Rota; M S Hirsch; S M Krane
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-01       Impact factor: 11.205

6.  A decade of experience with Mycobacterium tuberculosis culture from children: a seasonal influence on incidence of childhood tuberculosis.

Authors:  H S Schaaf; E D Nel; N Beyers; R P Gie; F Scott; P R Donald
Journal:  Tuber Lung Dis       Date:  1996-02

7.  Hypovitaminosis D is common among pulmonary tuberculosis patients in Tanzania but is not explained by the acute phase response.

Authors:  Henrik Friis; Nyagosya Range; Marianne L Pedersen; Christian Mølgaard; John Changalucha; Henrik Krarup; Pascal Magnussen; Christian Søborg; Ase B Andersen
Journal:  J Nutr       Date:  2008-12       Impact factor: 4.798

8.  A single dose of vitamin D enhances immunity to mycobacteria.

Authors:  Adrian R Martineau; Robert J Wilkinson; Katalin A Wilkinson; Sandra M Newton; Beate Kampmann; Bridget M Hall; Geoffrey E Packe; Robert N Davidson; Sandra M Eldridge; Zoë J Maunsell; Sandra J Rainbow; Jacqueline L Berry; Christopher J Griffiths
Journal:  Am J Respir Crit Care Med       Date:  2007-04-26       Impact factor: 21.405

9.  Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors.

Authors:  Elina Hyppönen; Chris Power
Journal:  Am J Clin Nutr       Date:  2007-03       Impact factor: 7.045

10.  Influence of a single oral dose of vitamin D(2) on serum 25-hydroxyvitamin D concentrations in tuberculosis patients.

Authors:  A R Martineau; A M Nanzer; K R Satkunam; G E Packe; S J Rainbow; Z J Maunsell; P M Timms; T R Venton; S M Eldridge; R N Davidson; R J Wilkinson; C J Griffiths
Journal:  Int J Tuberc Lung Dis       Date:  2009-01       Impact factor: 2.373

View more
  94 in total

1.  Shedding light on the vitamin D-tuberculosis-HIV connection.

Authors:  Susan Realegeno; Robert L Modlin
Journal:  Proc Natl Acad Sci U S A       Date:  2011-11-14       Impact factor: 11.205

2.  HIV-1 and the immune response to TB.

Authors:  Naomi F Walker; Graeme Meintjes; Robert J Wilkinson
Journal:  Future Virol       Date:  2013-01       Impact factor: 1.831

3.  High-dose vitamin D3 in adults with pulmonary tuberculosis: a double-blind randomized controlled trial.

Authors:  Nestan Tukvadze; Ekaterina Sanikidze; Maia Kipiani; Gautam Hebbar; Kirk A Easley; Neeta Shenvi; Russell R Kempker; Jennifer K Frediani; Veriko Mirtskhulava; Jessica A Alvarez; Nino Lomtadze; Lamara Vashakidze; Li Hao; Carlos Del Rio; Vin Tangpricha; Henry M Blumberg; Thomas R Ziegler
Journal:  Am J Clin Nutr       Date:  2015-09-23       Impact factor: 7.045

4.  Seasonal variations in serum vitamin D according to age and sex.

Authors:  Behzad Heidari; Maryam Beygom Haji Mirghassemi
Journal:  Caspian J Intern Med       Date:  2012

5.  Tuberculosis in transplantation: diagnosis, prevention, and treatment.

Authors:  Sarah Kirsch; Martina Sester
Journal:  Curr Infect Dis Rep       Date:  2012-12       Impact factor: 3.725

6.  Vitamin D deficiency among adult patients with tuberculosis: a cross sectional study from a national referral hospital in Uganda.

Authors:  Davis Kibirige; Edrisa Mutebi; Richard Ssekitoleko; William Worodria; Harriet Mayanja-Kizza
Journal:  BMC Res Notes       Date:  2013-07-25

Review 7.  Advancing host-directed therapy for tuberculosis.

Authors:  Robert S Wallis; Richard Hafner
Journal:  Nat Rev Immunol       Date:  2015-03-13       Impact factor: 53.106

Review 8.  Vitamin D supplementation and antibacterial immune responses in adolescents and young adults with HIV/AIDS.

Authors:  Rene F Chun; Nancy Q Liu; T Lee; Joan I Schall; Michelle R Denburg; Richard M Rutstein; John S Adams; Babette S Zemel; Virginia A Stallings; Martin Hewison
Journal:  J Steroid Biochem Mol Biol       Date:  2014-08-01       Impact factor: 4.292

9.  Vitamin D rescues impaired Mycobacterium tuberculosis-mediated tumor necrosis factor release in macrophages of HIV-seropositive individuals through an enhanced Toll-like receptor signaling pathway in vitro.

Authors:  Asha Anandaiah; Sanjeev Sinha; Medhavi Bole; Surendra K Sharma; Narendra Kumar; Kalpana Luthra; Xin Li; Xiuqin Zhou; Benjamin Nelson; Xinbing Han; Souvenir D Tachado; Naimish R Patel; Henry Koziel
Journal:  Infect Immun       Date:  2012-10-15       Impact factor: 3.441

10.  CD40 ligand and interferon-γ induce an antimicrobial response against Mycobacterium tuberculosis in human monocytes.

Authors:  Georgiana M Klug-Micu; Steffen Stenger; Andrea Sommer; Philip T Liu; Stephan R Krutzik; Robert L Modlin; Mario Fabri
Journal:  Immunology       Date:  2013-05       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.